Results
76,369 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | McClain SeanDirector, Chief Executive Officer |  ABSIAbsci CorpTax withholding | F | $603K 59.9K sh | Jun 26, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | McClain SeanDirector, Chief Executive Officer | ABSIAbsci Corp Tax withholding | F | $603K 59.9K sh | Jun 26, 2026 |
| 15 | Dishart NoreenExecutive VP/Chief HR Officer |  PRAPROASSURANCE CORPDisposition to issuer | D | $682K 27.9K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 15 | Van Tuyl ChristopherChief Legal Officer |  IMVTImmunovant, Inc.Option exercise | M | $271K 17.8K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 15 | Galla Christopher TSVP, GC, and Corp. Secretary |  GPCGENUINE PARTS COOpen-market sale · 10b5-1 plan | SELL | $268K 2,333 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 14 | Venker EricPresident & Immunovant CEO |  ROIVRoivant Sciences Ltd.Open-market sale · 10b5-1 plan | SELL | $5.08M 153.8K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer |  AALAmerican Airlines Group Inc.Open-market sale · 10b5-1 plan | SELL | $1.02M 56.5K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer | AALAmerican Airlines Group Inc. Open-market sale · 10b5-1 plan | SELL | $1.18M 69.3K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer |  CRCLCircle Internet Group, Inc.Open-market sale · 10b5-1 plan | SELL | $101K 1,334 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Rubin KevinChief Financial Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $70K 560 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | DeSimone JillDirector |  PRAXPraxis Precision Medicines, Inc.Option exercise · 10b5-1 plan | M | $447K 3,034 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 1,696 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Bohnert Christopher HSVP, Chief Financial Officer |  NNBRNN INCTax withholding | F | $25K 9,205 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Van Tuyl ChristopherChief Legal Officer | IMVTImmunovant, Inc. Option exercise | M | — 17.8K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 13 | Menu PhilippeChief Medical Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $28K 5,000 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Frazier WilliamDirector, Chief Medical Officer |  VMDVIEMED HEALTHCARE, INC.Option exercise | M | $18K 10.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Hughes AaronDirector |  SSentinelOne, Inc.Grant or award | A | — 4,176 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 504 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $5.57M 138.1K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Caldwell Jonathan L.Chief People Officer |  VVVVALVOLINE INCOpen-market sale · 10b5-1 plan | SELL | $114K 2,851 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Wierbicki PaulDirector, Chief Legal Officer |  RSIRush Street Interactive, Inc.Option exercise | M | $74K 6,926 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Leibrock Robert WilliamChief Financial Officer |  ACIWACI WORLDWIDE, INC.Disposition to issuer | D | $114K 2,454 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | DeSimone JillDirector | PRAXPraxis Precision Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 683 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $2.50M 61.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 12 | Burrows Scott LChief Financial Officer |  SYRESpyre Therapeutics, Inc.Option exercise | M | $218K 15.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $1.28M 5,066 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | DeSimone JillDirector | PRAXPraxis Precision Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $158K 504 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 11 | Sakamoto Ryan T.EVP, Chief Legal Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $11K 2,978 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 11 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOpen-market sale · 10b5-1 plan | SELL | $296K 7,539 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 11 | Islam NayaabSee Remarks |  STUBStubHub Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $302K 25.1K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 10 | Venker EricPresident & Immunovant CEO | ROIVRoivant Sciences Ltd. Open-market sale · 10b5-1 plan | SELL | $1.55M 46.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 228 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 10 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $1,521 12 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Patrick KristinDirector |  NAGENiagen Bioscience, Inc.Grant or award | A | — 31.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Shahbazi HamedDirector | NAGENiagen Bioscience, Inc. Grant or award | A | — 31.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Kowalski Jessica PatriciaEVP and GM, Research |  WLYWLYBJOHN WILEY & SONS, INC.Grant or award | A | — 20.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Linz Terrence JamesPresident, Wholesale Brands |  LZBLA-Z-BOY INCTax withholding | F | $20K 482 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Ware Olivia CDirector |  CTNMContineum Therapeutics, Inc.Grant or award | A | — 19.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | Vanderjagt Katherine E.VP & Chief HR Officer | LZBLA-Z-BOY INC Tax withholding | F | $17K 408 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Sundy Robert IIPresident, Retail | LZBLA-Z-BOY INC Tax withholding | F | $21K 497 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Hendricks Dana SChief Financial Officer | PRAPROASSURANCE CORP Disposition to issuer | D | — 23.7K sh | Jun 26, 2026 traded Jun 26, 2026 |